The Blumberg Institute is at the forefront of groundbreaking research to understand the hepatitis B virus, develop better treatments, and ultimately find a cure. Our scientists also are pioneering non-invasive methods to diagnose cirrhosis and liver cancer at earlier, more treatable stages.

Despite our incredible progress, much work remains. With 300 million people worldwide living with hepatitis B and at risk for cirrhosis and liver cancer, accelerating our research is crucial. This life-saving work depends on generous support from donors like you. Your contribution can advance our research and potentially save millions of lives.

Please consider donating today to support our vital mission.